Amy Comander - Concepedia

Author

Amy Comander

Also Known As

A Comander, A. Comander, A. H. Comander, A.H. COMANDER, A.H. Comander, Amy Comander, Amy H Comander, Amy H. Comander, Mariana Chavez-MacGregor, Mariana Chávez-MacGregor

Publications

682

Citations

H-Index

Concepts

All Affiliations

Harvard University Massachusetts General Hospital Dana-Farber Cancer Institute Beth Israel Deaconess Medical Center Dana-Farber Brigham Cancer Center

About

Amy Comander is an author at Harvard University specializing in radiation oncology, breast cancer, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	70
2	Nursing	2	2	38
3	Health Sciences	1	1	33
4	Public Health	1	1	23
5	Family Medicine	1	1	23

Amy Comander

Publications

539

Citations

H-Index

Page 1

	Year	Citations
Selection of Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer: ASCO Guideline Update Neelima Denduluri, Mark R. Somerfield, Mariana Chávez‐MacGregor, Journal of Clinical Oncology	2020	100
Estrogen receptor positive breast cancers in BRCA1 mutation carriers: clinical risk factors and pathologic features Nadine Tung, Yihong Wang, Laura C. Collins, Breast Cancer Research	2010	92
Clinical outcome of triple negative breast cancer in <i>BRCA1</i> mutation carriers and noncarriers Larissa J. Lee, Brian M. Alexander, Stuart J. Schnitt, Cancer	2011	78
Isocitrate Dehydrogenase 1 (<i>IDH1</i>) Mutation in Breast Adenocarcinoma Is Associated With Elevated Levels of Serum and Urine 2-Hydroxyglutarate Amir T. Fathi, Hossein Sadrzadeh, Amy Comander, The Oncologist	2014	74
Response-guided neoadjuvant sacituzumab govitecan for localized triple-negative breast cancer: results from the NeoSTAR trial Laura M. Spring, Sara M. Tolaney, Geoffrey Fell, Annals of Oncology	2023	63
Phase 2 study of response-guided neoadjuvant sacituzumab govitecan (IMMU-132) in patients with localized triple-negative breast cancer: Results from the NeoSTAR trial. Laura M. Spring, Sara M. Tolaney, Neelam V. Desai, Journal of Clinical Oncology Breast OncologyCancer ManagementImmunologyPathologyImmunotherapeutics	2022	33
The Survivorship Sleep Program (SSP): A synchronous, virtual cognitive behavioral therapy for insomnia pilot program among cancer survivors Daniel L. Hall, Kimberly A. Arditte Hall, Mark Gorman, Cancer	2021	26
PAVING the Path to Wellness for Breast Cancer Survivors: Lifestyle Medicine Education and Group Interventions Amy Comander, Beth Frates, Michelle Tollefson American Journal of Lifestyle Medicine Family MedicineUnited StatesCancer EducationGroup InterventionsLifestyle Support	2021	23
Effectiveness and tolerability of neoadjuvant pertuzumab-containing regimens for HER2-positive localized breast cancer Laura M. Spring, Andrzej Niemierko, Stephanie Haddad, Breast Cancer Research and Treatment Breast OncologyNeoadjuvant Pertuzumab-containing RegimensMedicinePathologyImmune Checkpoint Inhibitor	2018	22
Development and Refinement of a Telehealth Intervention for Symptom Management, Distress, and Adherence to Adjuvant Endocrine Therapy after Breast Cancer Jamie M. Jacobs, Emily A. Walsh, Chelsea S. Rapoport, Journal of Clinical Psychology in Medical Settings NursingBreast OncologyOncologyAdjuvant Endocrine TherapyCancer Management	2020	15

Page 1